Načítá se...
Development of an enzyme-linked immunosorbent assay for Keap1-Nrf2 interaction inhibitors identification
Development of Keap1–Nrf2 interaction inhibitors is a promising strategy for the discovery of therapeutic agents against oxidative stress-mediated diseases. Two motifs of Nrf2, ETGE and DLG motif, are responsible for Keap1-Nrf2 binding. Previously, ETGE peptide or ETGE-derived peptide-based approach...
Uloženo v:
| Vydáno v: | Redox Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7231848/ https://ncbi.nlm.nih.gov/pubmed/32422542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2020.101573 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|